0Studies tracked
0Claims cite
0Videos use
Average study score: 42/100
Bibliography
Studies by this author
2 studies attributed to Rama Suresh on the platform. Click a card to read the full analysis.
Study
A pilot study of liposomal irinotecan plus 5-FU/LV combined with paricalcitol in patients with advanced pancreatic cancer whose disease progressed on gemcitabine-based therapy.
Pilot study assessing safety and preliminary efficacy of adding paricalcitol to liposomal irinotecan plus 5-FU/LV in patients with advanced pancreatic cancer whose disease progressed on gemcitabine-based therapy.
Study
A pilot study of paricalcitol plus nanoliposomal irinotecan and 5-FU/LV in advanced pancreatic cancer patients after progression on gemcitabine-based therapy
Single-institution, open-label pilot trial evaluating safety and preliminary efficacy of adding paricalcitol (a vitamin D analogue) to nanoliposomal irinotecan plus 5-FU/LV in patients with advanced pancreatic cancer who progressed on gemcitabine-based therapy. Not retracted; no corrections reported.